Expert Review of Anticancer Therapy, Volume 15, Issue 9 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 15, Issue 9 (2015)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Volume 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Should docetaxel be administered earlier in prostate cancer therapy?
Julie N Graff & Tomasz M Beer
Pages: 977-979
Published online: 29 Jul 2015
AbstractforShould docetaxel be administered earlier in prostate cancer therapy? | Full Text | References | PDF (347.2 KB)
  • 1869 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma
Elnaz Faghfuri, Mohammad Ali Faramarzi, Shekoufeh Nikfar & Mohammad Abdollahi
Pages: 981-993
Published online: 30 Jul 2015
AbstractforNivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma | Full Text | References | PDF (403.4 KB)
  • 1116 Views
  • 46 CrossRef citations
  • 0Altmetric
Pazopanib in ovarian cancer
Jennifer McLachlan & Susana Banerjee
Pages: 995-1005
Published online: 20 Aug 2015
AbstractforPazopanib in ovarian cancer | Full Text | References | PDF (262.9 KB)
  • 634 Views
  • 12 CrossRef citations
  • 0Altmetric
ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer
Karim Fizazi, Laurence Albiges, Yohann Loriot & Christophe Massard
Pages: 1007-1017
Published online: 26 Aug 2015
AbstractforODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer | Full Text | References | PDF (679.3 KB)
  • 4459 Views
  • 55 CrossRef citations
  • 0Altmetric
Open Access

Review

The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes
Abdallah Abou Zahr, Ehab Saad Aldin, Lisa Barbarotta, Nikolai Podoltsev & Amer M Zeidan
Pages: 1019-1036
Published online: 17 Aug 2015
AbstractforThe clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes | Full Text | References | PDF (745.2 KB)
  • 359 Views
  • 17 CrossRef citations
  • 0Altmetric
Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide
Alessandra Modena, Chiara Ciccarese, Emanuela Fantinel, Davide Bimbatti, Giampaolo Tortora & Francesco Massari
Pages: 1037-1048
Published online: 01 Jul 2015
AbstractforMetastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide | Full Text | References | PDF (439.8 KB)
  • 548 Views
  • 5 CrossRef citations
  • 0Altmetric
The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target
Lateef A Muhammad & Fred Saad
Pages: 1049-1061
Published online: 26 Aug 2015
AbstractforThe role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target | Full Text | References | PDF (1 MB)
  • 460 Views
  • 18 CrossRef citations
  • 0Altmetric
Echo-endoscopic lymph node staging in lung cancer: an endoscopic alternative
Pravachan Hegde & Moishe Liberman
Pages: 1063-1073
Published online: 11 Jul 2015
AbstractforEcho-endoscopic lymph node staging in lung cancer: an endoscopic alternative | Full Text | References | PDF (2.2 MB)
  • 184 Views
  • 3 CrossRef citations
  • 0Altmetric
Drug transporters in breast cancer: response to anthracyclines and taxanes
Iben Kümler, Jan Stenvang, José Moreira, Nils Brünner & Dorte Lisbet Nielsen
Pages: 1075-1092
Published online: 26 Aug 2015
AbstractforDrug transporters in breast cancer: response to anthracyclines and taxanes | Full Text | References | PDF (337.6 KB)
  • 212 Views
  • 6 CrossRef citations
  • 0Altmetric
Geographic/ethnic variability of chromosomal and molecular abnormalities in leukemia
Marc De Braekeleer, Etienne De Braekeleer & Nathalie Douet-Guilbert
Pages: 1093-1102
Published online: 27 Jul 2015
AbstractforGeographic/ethnic variability of chromosomal and molecular abnormalities in leukemia | Full Text | References | PDF (351.7 KB) | Supplemental
  • 196 Views
  • 4 CrossRef citations
  • 0Altmetric
Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
Asa Dahle-Smith & Russell D Petty
Pages: 1103-1119
Published online: 02 Aug 2015
AbstractforBiomarkers and novel agents in esophago-gastric cancer: are we making progress? | Full Text | References | PDF (690.4 KB)
  • 229 Views
  • 6 CrossRef citations
  • 0Altmetric

Erratum

Correction
Erratum
Page: 1121
Published online: 21 Jul 2015
CitationforErratum | Full Text | PDF (29.6 KB)
  • 580 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?
Pasquale Vitale et al.
Editorial | Published online: 13 May 2024
Free Access
The role of planetary health in urologic oncology
Laura Lawaczeck et al.
Review Article | Published online: 11 May 2024
Open Access
The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies
Bahareh Kashani et al.
Review Article | Published online: 8 May 2024
Is there a link between talcum powder, oxidative stress, and ovarian cancer risk?
Ghassan M. Saed
Comment | Published online: 8 May 2024
View all latest articles